ATE365541T1 - Granulate von arzneistoffsalzen mit hydrolisierter cellulose - Google Patents

Granulate von arzneistoffsalzen mit hydrolisierter cellulose

Info

Publication number
ATE365541T1
ATE365541T1 AT00966863T AT00966863T ATE365541T1 AT E365541 T1 ATE365541 T1 AT E365541T1 AT 00966863 T AT00966863 T AT 00966863T AT 00966863 T AT00966863 T AT 00966863T AT E365541 T1 ATE365541 T1 AT E365541T1
Authority
AT
Austria
Prior art keywords
granules
medicinal salts
hydrolized
cellulose
hydrolized cellulose
Prior art date
Application number
AT00966863T
Other languages
English (en)
Inventor
David Erkoboni
Ronald Vladyka
Christopher Sweriduk
Andrew Favara
Original Assignee
Scherer Technologies Inc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Inc R P filed Critical Scherer Technologies Inc R P
Application granted granted Critical
Publication of ATE365541T1 publication Critical patent/ATE365541T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00966863T 1999-09-29 2000-09-26 Granulate von arzneistoffsalzen mit hydrolisierter cellulose ATE365541T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15654799P 1999-09-29 1999-09-29
US09/669,533 US6596312B1 (en) 1999-09-29 2000-09-26 Hydrolyzed cellulose granulations of salts of drugs

Publications (1)

Publication Number Publication Date
ATE365541T1 true ATE365541T1 (de) 2007-07-15

Family

ID=26853293

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00966863T ATE365541T1 (de) 1999-09-29 2000-09-26 Granulate von arzneistoffsalzen mit hydrolisierter cellulose

Country Status (12)

Country Link
US (2) US6596312B1 (de)
EP (1) EP1233755B1 (de)
AR (1) AR025879A1 (de)
AT (1) ATE365541T1 (de)
AU (1) AU777415B2 (de)
CA (1) CA2386312A1 (de)
DE (1) DE60035365T2 (de)
DK (1) DK1233755T3 (de)
ES (1) ES2288872T3 (de)
PT (1) PT1233755E (de)
TW (1) TWI236913B (de)
WO (1) WO2001022939A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US6705028B2 (en) * 2001-09-12 2004-03-16 Honda Giken Kogyo Kabushiki Kaisha Self-propelled snowplow vehicle
US20050123509A1 (en) * 2001-10-19 2005-06-09 Lehrman S. R. Modulating charge density to produce improvements in the characteristics of spray-dried proteins
AU2002335046A1 (en) * 2001-10-19 2003-05-06 Inhale Therapeutic Systems, Inc. The use of proton sequestering agents in drug formulations
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) * 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
EP1968523B1 (de) 2005-12-23 2012-02-15 GEA Process Engineering A/S Verfahren zur herstellung von tabletten
US7582679B2 (en) * 2006-02-03 2009-09-01 Pharmaceutics International Incorporated Compositions containing solid ibuprofen concentrates and methods of making solid ibuprofen concentrates
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
US20090104236A1 (en) * 2007-10-18 2009-04-23 Pharmaceutics International, Inc. Pharmaceutical solid hybrids

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL224413A (de) 1957-01-28
US3111513A (en) 1960-01-13 1963-11-19 Fmc Corp Oxidation derivatives of cellulose crystallite aggregates
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
US4859704A (en) * 1987-10-15 1989-08-22 Oratech Pharmaceutical Development Corporation Water soluble ibuprofen compositions and methods of making them
EP0619731B1 (de) 1991-12-30 2000-10-04 Fmc Corporation Zusammensetzung auf der basis von mikrokristalliner zellulose für die herstellung von kugelförmigen teilchen
US5585115A (en) 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5858409A (en) * 1996-04-17 1999-01-12 Fmc Corporation Hydrolyzed cellulose granulations for pharmaceuticals
DE69733752T2 (de) * 1996-05-20 2006-06-01 G.D. Searle Llc, Chicago Arzneimittel enthaltend oxaprozin-natriumsalz,-kaliumsalz, oder-tris(hydroxymethyl)aminomethansalz
US5712310A (en) 1996-06-14 1998-01-27 Alpharma Uspd, Inc. Suspension of substantially water-insoluble drugs and methods of their manufacture
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica

Also Published As

Publication number Publication date
DE60035365D1 (de) 2007-08-09
WO2001022939A1 (en) 2001-04-05
US20040081701A1 (en) 2004-04-29
EP1233755A4 (de) 2004-02-04
DE60035365T2 (de) 2008-02-28
AU777415B2 (en) 2004-10-14
ES2288872T3 (es) 2008-02-01
TWI236913B (en) 2005-08-01
CA2386312A1 (en) 2001-04-05
AU7714600A (en) 2001-04-30
EP1233755A1 (de) 2002-08-28
PT1233755E (pt) 2007-07-30
DK1233755T3 (da) 2007-10-29
EP1233755B1 (de) 2007-06-27
US6596312B1 (en) 2003-07-22
AR025879A1 (es) 2002-12-18

Similar Documents

Publication Publication Date Title
DE60012108D1 (de) Kontinuierliches Herstellungsverfahren von Wasser absorbierenden Polymeren
ATE300268T1 (de) Absorbierendes wegwerfartikel mit haltezonen
DE69502726D1 (de) Hestellung von aniontensidgranulaten
DE69928085D1 (de) Dosierungsform mit verlängerter wirkstoffabgabe
DE69713880D1 (de) Faseriges absorbierendes granulat
DE60004317D1 (de) Salze von Sulfonium-Verbindungen
DE60039814D1 (de) Absorbierender Artikel
DE60010824T2 (de) Katheter zur intermittierenden Selbst-Ableitung von Urin
DK1218009T3 (da) Quetiapingranulater
DE60038972D1 (de) Absorbierender artikel
DE60035365D1 (de) Granulate von arzneistoffsalzen mit hydrolisierter cellulose
PL354028A1 (pl) Farmaceutyczne roztwory levosimendanuFarmaceutyczne roztwory levosimendanu
DE50005284D1 (de) Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate mit antitumorwirkung
DE10084678T1 (de) Windel mit verringerter relativer Feuchtigkeit
NO20004072D0 (no) Absorberende artikkel
DE60029170D1 (de) Absorbierender Artikel
DE60027963D1 (de) Absorbierender Artikel
DE60022138D1 (de) Absorbierender Artikel
DE10084651T1 (de) Fehlertolerante Paritätsbildung
DE50004107D1 (de) Natriumvalproat-granulat mit verringerter hygroskopizität
DE60034800D1 (de) Wiederverschliessbarer absorbierender artikel
IS6007A (is) Ný morfólínóbensamíðsölt
EE200100017A (et) N-tert-butüülhüdroksüülamiini uued soolad
PT1253917E (pt) Utilizacao de compostos de 4-amino-1-fenilbutan-2-o1 substituidos como medicamentos
DE69942093D1 (de) Verwaltungsschema von Rundsendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1233755

Country of ref document: EP

REN Ceased due to non-payment of the annual fee